Annual CAPEX:
$159.00K-$836.00K(-84.02%)Summary
- As of today, AQST annual capital expenditures is $159.00 thousand, with the most recent change of -$836.00 thousand (-84.02%) on December 31, 2024.
- During the last 3 years, AQST annual CAPEX has fallen by -$754.00 thousand (-82.58%).
- AQST annual CAPEX is now -93.70% below its all-time high of $2.52 million, reached on December 31, 2022.
Performance
AQST CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$235.00K+$128.00K(+119.63%)Summary
- As of today, AQST quarterly capital expenditures is $235.00 thousand, with the most recent change of +$128.00 thousand (+119.63%) on September 30, 2025.
- Over the past year, AQST quarterly CAPEX has increased by +$155.00 thousand (+193.75%).
- AQST quarterly CAPEX is now -86.31% below its all-time high of $1.72 million, reached on September 30, 2022.
Performance
AQST Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$492.00K+$155.00K(+45.99%)Summary
- As of today, AQST TTM capital expenditures is $492.00 thousand, with the most recent change of +$155.00 thousand (+45.99%) on September 30, 2025.
- Over the past year, AQST TTM CAPEX has increased by +$332.00 thousand (+207.50%).
- AQST TTM CAPEX is now -83.77% below its all-time high of $3.03 million, reached on September 30, 2022.
Performance
AQST TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AQST CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -84.0% | +193.8% | +207.5% |
| 3Y3 Years | -82.6% | -86.3% | -83.8% |
| 5Y5 Years | -76.0% | +518.4% | +34.1% |
AQST CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -93.7% | at low | -86.3% | >+9999.0% | -83.8% | +209.4% |
| 5Y | 5-Year | -93.7% | at low | -86.3% | >+9999.0% | -83.8% | +209.4% |
| All-Time | All-Time | -93.7% | at low | -86.3% | >+9999.0% | -83.8% | +209.4% |
AQST CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $235.00K(+119.6%) | $492.00K(+46.0%) |
| Jun 2025 | - | $107.00K(-20.7%) | $337.00K(+27.2%) |
| Mar 2025 | - | $135.00K(+800.0%) | $265.00K(+66.7%) |
| Dec 2024 | $159.00K(-84.0%) | $15.00K(-81.3%) | $159.00K(-0.6%) |
| Sep 2024 | - | $80.00K(+128.6%) | $160.00K(-30.7%) |
| Jun 2024 | - | $35.00K(+20.7%) | $231.00K(-77.4%) |
| Mar 2024 | - | $29.00K(+81.3%) | $1.02M(+2.7%) |
| Dec 2023 | $995.00K(-60.6%) | $16.00K(-89.4%) | $995.00K(-1.0%) |
| Sep 2023 | - | $151.00K(-81.7%) | $1.00M(-60.9%) |
| Jun 2023 | - | $826.00K(>+9900.0%) | $2.57M(+6.2%) |
| Mar 2023 | - | $2000.00(-92.3%) | $2.42M(-4.0%) |
| Dec 2022 | $2.52M(+176.5%) | $26.00K(-98.5%) | $2.52M(-16.7%) |
| Sep 2022 | - | $1.72M(+153.6%) | $3.03M(+117.0%) |
| Jun 2022 | - | $677.00K(+551.0%) | $1.40M(+52.8%) |
| Mar 2022 | - | $104.00K(-80.5%) | $914.00K(+0.1%) |
| Dec 2021 | $913.00K | $533.00K(+542.2%) | $913.00K(+48.2%) |
| Sep 2021 | - | $83.00K(-57.2%) | $616.00K(+7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $194.00K(+88.3%) | $571.00K(+16.8%) |
| Mar 2021 | - | $103.00K(-56.4%) | $489.00K(-5.4%) |
| Dec 2020 | $517.00K(-22.0%) | $236.00K(+521.1%) | $517.00K(+40.9%) |
| Sep 2020 | - | $38.00K(-66.1%) | $367.00K(-12.6%) |
| Jun 2020 | - | $112.00K(-14.5%) | $420.00K(+0.5%) |
| Mar 2020 | - | $131.00K(+52.3%) | $418.00K(-37.0%) |
| Dec 2019 | $663.00K(-63.7%) | $86.00K(-5.5%) | $663.00K(-37.9%) |
| Sep 2019 | - | $91.00K(-17.3%) | $1.07M(-25.1%) |
| Jun 2019 | - | $110.00K(-70.7%) | $1.42M(-26.6%) |
| Mar 2019 | - | $376.00K(-23.3%) | $1.94M(+6.4%) |
| Dec 2018 | $1.82M(-11.8%) | $490.00K(+9.4%) | $1.82M(+28.3%) |
| Sep 2018 | - | $448.00K(-28.5%) | $1.42M(+46.0%) |
| Jun 2018 | - | $627.00K(+142.1%) | $974.00K(+180.7%) |
| Mar 2018 | - | $259.00K(+194.3%) | $347.00K(-53.4%) |
| Dec 2017 | $2.07M(+111.9%) | $88.00K(-86.6%) | $745.00K(+13.4%) |
| Mar 2017 | - | $657.00K | $657.00K |
| Dec 2016 | $976.00K | - | - |
FAQ
- What is Aquestive Therapeutics, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. annual CAPEX year-on-year change?
- What is Aquestive Therapeutics, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. quarterly CAPEX year-on-year change?
- What is Aquestive Therapeutics, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. TTM CAPEX year-on-year change?
What is Aquestive Therapeutics, Inc. annual capital expenditures?
The current annual CAPEX of AQST is $159.00K
What is the all-time high annual CAPEX for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high annual capital expenditures is $2.52M
What is Aquestive Therapeutics, Inc. annual CAPEX year-on-year change?
Over the past year, AQST annual capital expenditures has changed by -$836.00K (-84.02%)
What is Aquestive Therapeutics, Inc. quarterly capital expenditures?
The current quarterly CAPEX of AQST is $235.00K
What is the all-time high quarterly CAPEX for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high quarterly capital expenditures is $1.72M
What is Aquestive Therapeutics, Inc. quarterly CAPEX year-on-year change?
Over the past year, AQST quarterly capital expenditures has changed by +$155.00K (+193.75%)
What is Aquestive Therapeutics, Inc. TTM capital expenditures?
The current TTM CAPEX of AQST is $492.00K
What is the all-time high TTM CAPEX for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high TTM capital expenditures is $3.03M
What is Aquestive Therapeutics, Inc. TTM CAPEX year-on-year change?
Over the past year, AQST TTM capital expenditures has changed by +$332.00K (+207.50%)